Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects With Renal Anemia Not Requiring Dialysis and Not Receiving Recombinant Human Erythropoietin

NCT00456053 is registered in ClinicalTrials.gov with Kyntra Bio as lead sponsor.

NCT NCT00456053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00456053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects With Renal Anemia Not Requiring Dialysis and Not Receiving Recombinant Human Erythropoietin
Lead sponsor
Kyntra Bio
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2005
Completion date
July 31, 2007
Enrollment
145 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

renal anemia